C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2004
11/11/2004	WO2003059258A3 Compositions and methods for treating heart failure
11/11/2004	WO2000063175A3 Novel process
11/11/2004	US20040225109 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040224992 Antiinflammatory agents; antiallergens; antiproliferative agents; 4-(5-Fluoro-2-hydroxy-phenyl)-2-hydroxy-4-methyl-2-trifluoromethyl-pentanoic acid (3,5-dichloro-phenyl)-amide
11/11/2004	US20040224991 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
11/11/2004	US20040224984 Treatment of skin disorders and antiinflammatory agents, fungicides or bactericides
11/11/2004	US20040224978 CCR8 inhibitors
11/11/2004	US20040224975 Nicotinamide derivatives useful as PDE4 inhibitors
11/11/2004	US20040224959 such as N-benzyl-3-[4-(3,3-diphenyl-1-propyl)piperazin-1-yl]-N-methylbenzamide; for inhibition of secretion of apolipoprotein B lipoprotein from the liver; for treatment of hyperlipidemia, pancreatitis
11/11/2004	US20040224941 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/11/2004	US20040224928 For therapy of bacterial infections and neoplasms,
11/11/2004	US20040223915 Cytostatic cerium compounds
11/11/2004	US20040222401 Electrochemically stable onium salts and electrolytes containing such for electrochemical capacitors
11/11/2004	DE10318690B3 Verfahren zur Herstellung von Nicotinaldehyden A process for preparing nicotinaldehydes
11/11/2004	CA2536964A1 C-fms kinase inhibitors
11/10/2004	EP1474401A2 Novel aryl- and heteroarylpiperazines
11/10/2004	EP1474396A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/10/2004	EP1474395A1 Nicotinamide derivates useful as p38 inhibitors
11/10/2004	EP1474394A1 Pyridineamido derivatives as inhibitors of monoamine oxidase (mao-b)
11/10/2004	EP1474393A1 Aryl ureas as kinase inhibitors
11/10/2004	EP1474388A1 Astaxanthin esters
11/10/2004	EP1474380A2 4-dedimethylamino tetracycline compounds
11/10/2004	EP1474098A1 Sunscreen compositions as well as dihydropyridines and dihydropyranes
11/10/2004	EP1159258B1 Amide compounds for the potentiation of cholinergic activity
11/10/2004	EP1140181B1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia
11/10/2004	EP1085009B1 Indan derivatives
11/10/2004	EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE
11/10/2004	CN1545741A Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
11/10/2004	CN1545520A Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins
11/10/2004	CN1545501A Novel cyclohexyl sulphones
11/10/2004	CN1174745C Use of coating as taste masking agent for oral preparation
11/09/2004	US6815556 Killing plant diseases
11/09/2004	US6815546 Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
11/09/2004	US6815091 Iridium, rhodium, or palladium-phenylpyridine complex with specified substituent(s); high-efficiency luminescence, high brightness for a long time while minimizing deterioration in luminescence in energized state
11/04/2004	WO2004094413A1 Phenacyl 2-hydroxy-3-diaminoalkanes
11/04/2004	WO2004094384A2 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease
11/04/2004	WO2004094383A1 Method for the production of nicotinaldehydes
11/04/2004	WO2004094376A1 Hydroxamic acids useful in the treatment of hyper-proliferative disorders
11/04/2004	WO2004094363A1 Muscarinic agonists
11/04/2004	WO2004093879A1 (3-{3-‘(2,4-bis-trifluormethyl-benzyl)-(5-ethyl-pyrimidin-2-yl)-amino!-propoxy}-phenyl)-acetic acid and related compounds as modulators of ppars and methods of treating metabolic disorders
11/04/2004	WO2004080377A3 Kcnq channel modulating compounds and their pharmaceutical use
11/04/2004	WO2004078747A8 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
11/04/2004	WO2004069794A3 New arylpiperazinyl compounds
11/04/2004	WO2004067498A3 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/04/2004	WO2004057960A3 Compounds useful as pesticides
11/04/2004	WO2004056774A3 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	WO1999029693A8 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
11/04/2004	US20040220409 Reacting 4-fluoro-1-bromobenzene (VI) with 2,2,2-trifluoroethanol in the presence of a base and a copper-containing catalyst
11/04/2004	US20040220408 As anti-proliferative agents, therapy
11/04/2004	US20040220271 Fungicidal active compound combinations
11/04/2004	US20040220237 Asthma and allergic inflammation modulators
11/04/2004	US20040220236 4-Aryl quinols and analogs thereof as therapeutic agents
11/04/2004	US20040220235 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/04/2004	US20040220234 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
11/04/2004	US20040220232 Organometallic reagent reacted with an activated carboxylic acid to produce a ketone which is reacted with carbon disulfide and dihalomethane, further reacting the dithietane product with a secondary amine, and condensing the thioamide with hydrazine; useful as p38 kinase and COX-2 inhibitors
11/04/2004	US20040220225 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
11/04/2004	US20040220207 Chemokine receptor binding heterocyclic compounds
11/04/2004	US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004	US20040220192 antiserotonine agents; central nervous system disorders; anxiolytic agents; attention deficit disorders; strokes; headaches
11/04/2004	US20040220174 for example, 1-(4-methoxyphenyl)-7-oxo-6-[5-(2-oxo-1-piperidinyl)2-pyridinyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; use as anticoagulant agent for treatment of thromboembolic disorders
11/04/2004	US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004	US20040220172 Uracil substituted phenyl sulfamoyl carboxamides
11/04/2004	US20040220166 Half-sandwich ruthenium (II) compounds comprising nitrogen containing ligands ligands for treatment of cancer
11/04/2004	US20040220147 Antiarrhythmia agents; liver disorders; skin disorders
11/04/2004	US20040220112 administering 2-(N-Methylsulfonamido-2-aminophenyl)-N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]acetamide as an anti-pruritic agent; antihyperalgesics; analgesics; central nervous system side effect reduction
11/04/2004	US20040220055 Benzamidoacetonitriles and their use as antiparastics
11/04/2004	DE10318045A1 Stabile Ammoniumsalze der alpha-Liponsäure, ihre Herstellung und Verwendung Stable ammonium salts of the alpha-lipoic acid, their preparation and use
11/04/2004	CA2523232A1 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer's disease
11/04/2004	CA2522805A1 Phenacyl 2-hydroxy-3-diaminoalkanes
11/04/2004	CA2522565A1 Hydroxamic acids useful in the treatment of hyper-proliferative disorders
11/04/2004	CA2520908A1 Aryl compounds as modulators of ppars and methods of treating metabolic disorders
11/04/2004	CA2518700A1 Muscarinic agonists
11/03/2004	EP1473286A1 Process for producing biaryl compound
11/03/2004	EP1472377A2 Genetic polymorphisms in the preprotachykinin gene
11/03/2004	EP1472226A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
11/03/2004	EP1472225A2 2-piperazine-pyridines useful for treating pain
11/03/2004	EP1472224A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
11/03/2004	EP1472216A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
11/03/2004	EP1472215A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
11/03/2004	EP1472214A2 Compounds for inhibiting insulin secretion and methods related thereto
11/03/2004	EP1472208A1 Novel 3-aryl-2,5-dihydroxy-1,4-benzoquinone derivatives, their preparation method and pharmaceutical compositions containing same
11/03/2004	EP1445251A9 Aminoacetonitrile derivative, agricultural and horticultural insecticide containing the same, and use thereof
11/03/2004	EP1377550B1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/03/2004	EP1294677B1 Benzophenones and sulfones as inhibitors of glycine uptake
11/03/2004	CN1543468A Processes for preparing calcium salt forms of statins
11/03/2004	CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004	CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)
11/03/2004	CN1543334A Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives
11/03/2004	CN1542002A Inhibitors of metalloproteinase, pharmaceutical compositions containing them, their pharmaceutical application and methods and intermediate compounds for their preparation
11/03/2004	CN1173971C Cycloalkyl-substituted aminomethylpyrrolidine derivatives
11/03/2004	CN1173953C Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
11/03/2004	CN1173952C N-hydroxy amidino compound preparation method
11/03/2004	CN1173951C Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use
11/03/2004	CN1173950C 2,3-Disubstituted pyridine derivatives, process for preparation thereof, drug compositions containing the same and intermediates for preparation
11/03/2004	CN1173949C Continuous processes for hydrolysis of cyanopyridines under substantially adiabatic conditions
11/03/2004	CN1173948C Alpha-substituted arylsulphonamido hydroxamic acids as TNF-alpha and matrix metalloproteinase inhibitors
11/03/2004	CN1173944C New vitamin-D derivatives with carbon ring or heterocyclic substitutents at C-25, process for the preparation, intermediate products and their use for producing medicaments
11/02/2004	US6812346 Antiinflammatory agents; antipyretics; analgesics

1 ... 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 ... 633